United Capital Financial Advisers, LLC Ionis Pharmaceuticals Inc Transaction History

United Capital Financial Advisers, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$47.45 - $62.95 $190,179 - $252,303	-4,008 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$46.85 - $61.05 $187,774 - $244,688	4,008 New	4,008 $236,000
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $184,163 - $280,671	-4,427 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $238,393 - $288,950	4,427 New	4,427 $267,000
Q3 2019 Nov 14, 2019	SELL	$59.06 - $72.15 $198,618 - $242,640	-3,363 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$52.92 - $81.17 $177,969 - $272,974	3,363 New	3,363 $273,000
Q1 2018 May 15, 2018	SELL	$44.08 - $55.05 $175,526 - $219,209	-3,982 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$50.3 - $64.39 $200,294 - $256,400	3,982	3,982 $200,000

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on United Capital Financial Advisers, LLC with notifications on news.